Insider Transactions in Q2 2024 at Dexcom Inc (DXCM)
Insider Transaction List (Q2 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 28
2024
|
Michael Jon Brown EVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
659
-0.98%
|
$75,126
$114.29 P/Share
|
Jun 18
2024
|
Mark G Foletta Director |
SELL
Open market or private sale
|
Indirect |
3,306
-2.78%
|
$386,802
$117.0 P/Share
|
Jun 17
2024
|
Mark G Foletta Director |
SELL
Open market or private sale
|
Indirect |
2,694
-1.45%
|
$312,504
$116.7 P/Share
|
Jun 14
2024
|
Bridgette P Heller Director |
SELL
Open market or private sale
|
Direct |
1,000
-3.8%
|
$113,000
$113.55 P/Share
|
Jun 10
2024
|
Jereme M Sylvain EVP, Chief Financal Officer |
SELL
Open market or private sale
|
Direct |
745
-0.87%
|
$85,675
$115.05 P/Share
|
Jun 10
2024
|
Jacob Steven Leach EVP, Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
745
-0.28%
|
$85,675
$115.05 P/Share
|
Jun 10
2024
|
Sadie Stern EVP, Chief HR Officer |
SELL
Open market or private sale
|
Direct |
427
-0.56%
|
$49,105
$115.05 P/Share
|
May 31
2024
|
Michael Jon Brown EVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
652
-0.96%
|
$77,588
$119.24 P/Share
|
May 22
2024
|
Richard Alexander Collins Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,632
+50.0%
|
-
|
May 22
2024
|
Karen M Dahut Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,613
+50.0%
|
-
|
May 22
2024
|
Rimma Driscoll Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,632
+28.39%
|
-
|
May 22
2024
|
Mark G Foletta Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,973
+50.0%
|
-
|
May 22
2024
|
Bridgette P Heller Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,618
+9.04%
|
-
|
May 22
2024
|
Kyle Malady Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,613
+12.59%
|
-
|
May 22
2024
|
Eric Topol Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,618
+50.0%
|
-
|
May 22
2024
|
Steven R Altman Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,613
+50.0%
|
-
|
May 22
2024
|
Nicholas Augustinos Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,618
+50.0%
|
-
|
May 18
2024
|
Steven R Altman Director |
BUY
Bona fide gift
|
Indirect |
2,885
+4.9%
|
-
|
May 18
2024
|
Steven R Altman Director |
SELL
Bona fide gift
|
Direct |
2,885
-100.0%
|
-
|
May 18
2024
|
Nicholas Augustinos Director |
BUY
Bona fide gift
|
Indirect |
3,043
+7.58%
|
-
|
May 18
2024
|
Nicholas Augustinos Director |
SELL
Bona fide gift
|
Direct |
3,043
-100.0%
|
-
|
May 18
2024
|
Richard Alexander Collins Director |
BUY
Bona fide gift
|
Indirect |
2,906
+6.88%
|
-
|
May 18
2024
|
Richard Alexander Collins Director |
SELL
Bona fide gift
|
Direct |
2,906
-100.0%
|
-
|
May 18
2024
|
Karen M Dahut Director |
BUY
Bona fide gift
|
Indirect |
2,906
+16.08%
|
-
|
May 18
2024
|
Karen M Dahut Director |
SELL
Bona fide gift
|
Direct |
2,906
-100.0%
|
-
|
May 18
2024
|
Mark G Foletta Director |
BUY
Bona fide gift
|
Indirect |
3,306
+5.03%
|
-
|
May 18
2024
|
Mark G Foletta Director |
SELL
Bona fide gift
|
Direct |
3,306
-100.0%
|
-
|
May 18
2024
|
Barbara Kahn Director |
BUY
Bona fide gift
|
Indirect |
2,927
+11.48%
|
-
|
May 18
2024
|
Barbara Kahn Director |
SELL
Bona fide gift
|
Direct |
2,927
-100.0%
|
-
|
May 18
2024
|
Eric Topol Director |
BUY
Bona fide gift
|
Indirect |
2,911
+0.76%
|
-
|
May 18
2024
|
Eric Topol Director |
SELL
Bona fide gift
|
Direct |
2,911
-100.0%
|
-
|
May 15
2024
|
Matthew Vincent Dolan EVP Strategy and Corporate Dev |
SELL
Open market or private sale
|
Direct |
2,423
-5.7%
|
$305,298
$126.58 P/Share
|
Apr 30
2024
|
Michael Jon Brown EVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
629
-0.91%
|
$79,254
$126.25 P/Share
|
Apr 15
2024
|
Matthew Vincent Dolan EVP Strategy and Corporate Dev |
SELL
Open market or private sale
|
Direct |
1,990
-4.49%
|
$272,630
$137.81 P/Share
|
Apr 08
2024
|
Kevin R Sayer President CEO and Chairman |
SELL
Open market or private sale
|
Direct |
49,633
-7.74%
|
$6,849,354
$138.34 P/Share
|